Literature DB >> 10457027

Are all helicobacters equal? Mechanisms of gastroduodenal pathology and their clinical implications.

A T Axon1.   

Abstract

Most cases of peptic ulcer disease, gastric mucosa associated lymphoid tissue (MALT) lymphoma and cancer of the distal stomach are complications of Helicobacter pylori infection. However, as with most infections not all patients who contract the infection develop the complications of the disease. The other factors that influence the likelihood of problems arising are the virulence of the infecting organism, the genetic constitution and age of the host, and environmental factors. This paper focuses mainly upon the effect of strain differences and the causation of serious disease. There is considerable genetic variation between the different strains of H pylori, some causing a more severe inflammatory response in the host than others. These strains are also associated with a greater likelihood of causing peptic ulcer, atrophic gastritis and intestinal metaplasia and gastric cancer. There is some evidence to suggest that these more virulent organisms may also protect the host from the development of reflux oesophagitis and possibly cancer in the region of the gastro-oesophageal junction. The major difference between virulent and relatively avirulent organisms depends upon the presence of the cag pathogenicity island, a segment of DNA that has been acquired possibly from another organism and is now incorporated within the helicobacter genome. Its presence is associated with the secretion of the vacuolating toxin which is a protein known to cause damage in cell culture and in vivo. As CagA, one of the proteins produced by the pathogenicity island, is highly antigenic, people infected with more virulent strains can be identified by a blood test. Currently controversy surrounds the question as to whether all patients with H pylori should be treated for infection or whether medication should be reserved for those who already have the complications of the infection, or individuals infected with the more virulent strain of the organism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457027      PMCID: PMC1766659          DOI: 10.1136/gut.45.2008.i1

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Cigarettes, alcohol, coffee and peptic ulcer.

Authors:  G D Friedman; A B Siegelaub; C C Seltzer
Journal:  N Engl J Med       Date:  1974-02-28       Impact factor: 91.245

2.  Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Authors:  J E Crabtree; J D Taylor; J I Wyatt; R V Heatley; T M Shallcross; D S Tompkins; B J Rathbone
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

3.  Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori.

Authors:  M K Tummuru; T L Cover; M J Blaser
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

Review 4.  Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease.

Authors:  A Lee; M F Dixon; S J Danon; E Kuipers; F Mégraud; H Larsson; B Mellgård
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-05       Impact factor: 2.566

Review 5.  Production of a cytotoxin by Helicobacter pylori.

Authors:  R D Leunk
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

6.  Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis.

Authors:  J I Wyatt; B J Rathbone; M F Dixon; R V Heatley
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

7.  A case-control study of gastric cancer and diet in Italy: II. Association with nutrients.

Authors:  E Buiatti; D Palli; A Decarli; D Amadori; C Avellini; S Bianchi; C Bonaguri; F Cipriani; P Cocco; A Giacosa
Journal:  Int J Cancer       Date:  1990-05-15       Impact factor: 7.396

8.  Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity.

Authors:  T L Cover; C P Dooley; M J Blaser
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

9.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.

Authors:  M J Blaser; G I Perez-Perez; H Kleanthous; T L Cover; R M Peek; P H Chyou; G N Stemmermann; A Nomura
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

10.  Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.

Authors:  J L Telford; P Ghiara; M Dell'Orco; M Comanducci; D Burroni; M Bugnoli; M F Tecce; S Censini; A Covacci; Z Xiang
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  7 in total

1.  Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer.

Authors:  Yusuf Erzin; Sibel Altun; Ahmet Dobrucali; Mustafa Aslan; Sibel Erdamar; Ahmet Dirican; Murat Tuncer; Bekir Kocazeybek
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

Review 2.  A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.

Authors:  Elvira Garza-González; Guillermo Ignacio Perez-Perez; Héctor Jesús Maldonado-Garza; Francisco Javier Bosques-Padilla
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

3.  Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells.

Authors:  Junzo Hisatsune; Eiki Yamasaki; Masaaki Nakayama; Daisuke Shirasaka; Hisao Kurazono; Yohtaro Katagata; Hiroyasu Inoue; Jiahuai Han; Jan Sap; Kinnosuke Yahiro; Joel Moss; Toshiya Hirayama
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

4.  Effects of Helicobacter suis γ-glutamyl transpeptidase on lymphocytes: modulation by glutamine and glutathione supplementation and outer membrane vesicles as a putative delivery route of the enzyme.

Authors:  Guangzhi Zhang; Richard Ducatelle; Frank Pasmans; Katharina D'Herde; Liping Huang; Annemieke Smet; Freddy Haesebrouck; Bram Flahou
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

Review 5.  Epidemiology and pattern of antibiotic resistance in Helicobacter pylori: scenario from Saudi Arabia.

Authors:  Mohammed Rizwan; Nuzhath Fatima; Ayesha Alvi
Journal:  Saudi J Gastroenterol       Date:  2014 Jul-Aug       Impact factor: 2.485

6.  Both diet and Helicobacter pylori infection contribute to atherosclerosis in pre- and postmenopausal cynomolgus monkeys.

Authors:  Traci L Testerman; Cristina Semino-Mora; Jennifer A Cann; Beidi Qiang; Edsel A Peña; Hui Liu; Cara H Olsen; Haiying Chen; Susan E Appt; Jay R Kaplan; Thomas C Register; D Scott Merrell; Andre Dubois
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

Review 7.  Helicobacter pylori Infection, Virulence Genes' Distribution and Accompanying Clinical Outcomes: The West Africa Situation.

Authors:  Eric Gyamerah Ofori; Cynthia Ayefoumi Adinortey; Ansumana Sandy Bockarie; Foster Kyei; Emmanuel Ayitey Tagoe; Michael Buenor Adinortey
Journal:  Biomed Res Int       Date:  2019-12-10       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.